newsfilter
← Latest News
ACCESS Newswire·

Jaguar Health to Hold Investor Webcast August 19 Regarding Q2 2026 Financials & Corporate Updates

  • Jaguar Health, Inc. (NASDAQ: JAGX) will file its Form 10-Q earnings report on August 19, 2026, for the quarter ended June 30, 2026.
  • The company will conduct an investor webcast on Wednesday, August 19, 2026, at 4:30 p.m. Eastern to review second-quarter 2026 financials & provide corporate updates.
  • A replay of the webcast will be available on the investor relations section of Jaguar's website.
  • Jaguar Health develops proprietary prescription drugs from plants for gastrointestinal disease states.
  • Napo Pharmaceuticals & Napo Therapeutics focus on crofelemer powder for rare gastrointestinal disorders including microvillus inclusion disease & short bowel syndrome.
  • Magdalena Biosciences, a joint venture between Jaguar & Filament Health Corp., develops plant-derived medicines for mental health indications.